Osteoarthritis (OA) is a chronic, prevalent, debilitating joint disease characterized by
progressive cartilage degradation, subchondral bone remodeling, bone marrow lesions …

Objective To examine the effect of different sources of Good Manufacturing Practice clinical
grade adipose‐derived mesenchymal stem cells (AD‐MSCs) on inflammatory factors in …

Mesenchymal stem cells (MSCs) can protect against cartilage breakdown in osteoarthritis
(OA) via their immunomodulatory capacities. However, the optimization strategy for using …

This study was purposed to investigate the influence of inflammatory microenvironment on
mesenchymal stem cells (MSCs) and regulatory effect of MSCs on osteoblast formation. The …

Background Joint surface injury, a known risk factor for osteoarthritis, triggers synovial
hyperplasia, which involves proliferation of mesenchymal stromal/stem cells (MSCs) …

Background: Mesenchymal stem cells (MSCs) are a promising treatment of different
musculoskeletal diseases including osteoarthritis and rheumatoid arthritis (RA). Results from …

Background Articular injection of mesenchymal stem cells (MSCs) has been applied to treat
knee osteoarthritis (kOA), but its clinical outcomes are controversial. This study investigated …

Rheumatoid arthritis is a chronic and systemic autoimmune disease characterized by
inflammatory cell infiltration and joint erosion. Human adipose-derived mesenchymal stem …

Osteoarthritis (OA), a common disease that originates from cartilage damage, affects
approximately 250 million people around the world (1). The disease is more common in …

Introduction: Mesenchymal stem cells (MSCs) are multipotent stromal cells characterized by
their ability to differentiate into adipocytes, chondrocytes, osteocytes and a number of other …